JP2001523644A5 - - Google Patents

Download PDF

Info

Publication number
JP2001523644A5
JP2001523644A5 JP2000520798A JP2000520798A JP2001523644A5 JP 2001523644 A5 JP2001523644 A5 JP 2001523644A5 JP 2000520798 A JP2000520798 A JP 2000520798A JP 2000520798 A JP2000520798 A JP 2000520798A JP 2001523644 A5 JP2001523644 A5 JP 2001523644A5
Authority
JP
Japan
Prior art keywords
methyl
dideoxy
ketolide
ribohexopyranosyl
oxycarbonyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000520798A
Other languages
English (en)
Japanese (ja)
Other versions
JP4550273B2 (ja
JP2001523644A (ja
Filing date
Publication date
Priority claimed from FR9714358A external-priority patent/FR2771008B1/fr
Application filed filed Critical
Publication of JP2001523644A publication Critical patent/JP2001523644A/ja
Publication of JP2001523644A5 publication Critical patent/JP2001523644A5/ja
Application granted granted Critical
Publication of JP4550273B2 publication Critical patent/JP4550273B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000520798A 1997-11-17 1998-11-16 アテローム性動脈硬化症と結びついた動脈血栓合併症を予防するための製薬組成物の製造のためのケトリドの使用 Expired - Fee Related JP4550273B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9714358A FR2771008B1 (fr) 1997-11-17 1997-11-17 Utilisation des ketolides pour la preparation de compositions pharmaceutiques destinees a prevenir les complications thrombotiques arterielles liees a l'atherosclerose
FR97/14358 1997-11-17
PCT/FR1998/002436 WO1999025365A1 (fr) 1997-11-17 1998-11-16 Utilisation des ketolides pour prevenir les complications thrombotiques arterielles liees a l'atherosclerose

Publications (3)

Publication Number Publication Date
JP2001523644A JP2001523644A (ja) 2001-11-27
JP2001523644A5 true JP2001523644A5 (cg-RX-API-DMAC7.html) 2006-01-12
JP4550273B2 JP4550273B2 (ja) 2010-09-22

Family

ID=9513423

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000520798A Expired - Fee Related JP4550273B2 (ja) 1997-11-17 1998-11-16 アテローム性動脈硬化症と結びついた動脈血栓合併症を予防するための製薬組成物の製造のためのケトリドの使用

Country Status (35)

Country Link
US (1) US20080139489A1 (cg-RX-API-DMAC7.html)
EP (1) EP1030673B1 (cg-RX-API-DMAC7.html)
JP (1) JP4550273B2 (cg-RX-API-DMAC7.html)
KR (1) KR20010032130A (cg-RX-API-DMAC7.html)
CN (1) CN1286633A (cg-RX-API-DMAC7.html)
AP (1) AP1196A (cg-RX-API-DMAC7.html)
AR (1) AR014119A1 (cg-RX-API-DMAC7.html)
AT (1) ATE271875T1 (cg-RX-API-DMAC7.html)
AU (1) AU744419B2 (cg-RX-API-DMAC7.html)
BG (1) BG104427A (cg-RX-API-DMAC7.html)
BR (1) BR9814199A (cg-RX-API-DMAC7.html)
CA (1) CA2312021C (cg-RX-API-DMAC7.html)
DE (1) DE69825308T2 (cg-RX-API-DMAC7.html)
DZ (1) DZ2654A1 (cg-RX-API-DMAC7.html)
EA (1) EA003322B1 (cg-RX-API-DMAC7.html)
EE (1) EE04095B1 (cg-RX-API-DMAC7.html)
ES (1) ES2224446T3 (cg-RX-API-DMAC7.html)
FR (1) FR2771008B1 (cg-RX-API-DMAC7.html)
GE (1) GEP20032968B (cg-RX-API-DMAC7.html)
HR (1) HRP20000314A2 (cg-RX-API-DMAC7.html)
HU (1) HUP0004507A3 (cg-RX-API-DMAC7.html)
ID (1) ID24940A (cg-RX-API-DMAC7.html)
IL (1) IL136149A0 (cg-RX-API-DMAC7.html)
MA (1) MA26566A1 (cg-RX-API-DMAC7.html)
NO (1) NO20002435L (cg-RX-API-DMAC7.html)
NZ (1) NZ504305A (cg-RX-API-DMAC7.html)
OA (1) OA11411A (cg-RX-API-DMAC7.html)
PL (1) PL340373A1 (cg-RX-API-DMAC7.html)
SK (1) SK7042000A3 (cg-RX-API-DMAC7.html)
TN (1) TNSN98206A1 (cg-RX-API-DMAC7.html)
TR (1) TR200001384T2 (cg-RX-API-DMAC7.html)
TW (1) TW472061B (cg-RX-API-DMAC7.html)
WO (1) WO1999025365A1 (cg-RX-API-DMAC7.html)
YU (1) YU29600A (cg-RX-API-DMAC7.html)
ZA (1) ZA9810357B (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2777282B1 (fr) * 1998-04-08 2001-04-20 Hoechst Marion Roussel Inc Nouveaux derives de la 2-fluoro 3-de((2,6-dideoxy 3-c-methyl 3-0-methyl-alpha-l-ribohexopyranosyl) oxyl) 6-o-methyl 3-oxo erythromycine, leur procede de preparation et leur application a la synthese de principes actifs de medicaments
ATE344269T1 (de) * 1998-12-10 2006-11-15 Pfizer Prod Inc Carbamat und carbazat ketolid antibiotika
DK1147121T3 (da) * 1999-01-27 2004-04-13 Pfizer Prod Inc Ketolidantibiotika
EP1114826A3 (en) * 1999-12-29 2001-10-31 Pfizer Products Inc. Novel antibacterial and prokinetic macrolides
HUP0300370A3 (en) 2000-04-04 2005-07-28 Smithkline Beecham Plc 2-hydroxy-mutilin carbamate derivatives of antibacterial effect process for preparation and pharmaceutical compositions containing them
JP2004323414A (ja) * 2003-04-24 2004-11-18 Japan Science & Technology Agency 14員環マクロライド化合物を利用した、血管平滑筋の増殖に起因する疾患治療剤
GB0402578D0 (en) * 2004-02-05 2004-03-10 Cambridge Theranostics Ltd Methods of treatment of atherosclerosis
KR20130120458A (ko) * 2010-09-10 2013-11-04 셈프라 파마슈티컬스, 인크. 질환을 치료하기 위한 수소결합 형성 플루오로 케토라이드

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2249892A (en) * 1991-06-14 1993-01-12 Board Of Regents Of The University Of Washington, The Diagnosis and treatment of arterial chlamydial granuloma
FR2718450B1 (fr) * 1994-04-08 1997-01-10 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2742757B1 (fr) * 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
US6271255B1 (en) * 1996-07-05 2001-08-07 Biotica Technology Limited Erythromycins and process for their preparation
GB9621771D0 (en) * 1996-10-18 1996-12-11 St George S Enterprises Ltd Method of treatment of heart disease
FR2757168B1 (fr) * 1996-12-12 1999-06-11 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
EP0895999A1 (en) * 1997-08-06 1999-02-10 Pfizer Products Inc. C-4" substituted macrolide antibiotics

Similar Documents

Publication Publication Date Title
EP1772142A3 (en) Organic compounds
JP2002519434A5 (cg-RX-API-DMAC7.html)
JP2003509349A5 (cg-RX-API-DMAC7.html)
JP2003531118A5 (cg-RX-API-DMAC7.html)
JP2002332234A5 (cg-RX-API-DMAC7.html)
JP2003523927A5 (cg-RX-API-DMAC7.html)
JP2002517491A5 (cg-RX-API-DMAC7.html)
JP2002525323A5 (cg-RX-API-DMAC7.html)
JP2001526218A5 (cg-RX-API-DMAC7.html)
JP2004520292A5 (cg-RX-API-DMAC7.html)
JP2002541233A5 (cg-RX-API-DMAC7.html)
JP2004506740A5 (cg-RX-API-DMAC7.html)
JP2003502367A5 (cg-RX-API-DMAC7.html)
JP2007508336A5 (cg-RX-API-DMAC7.html)
KR950016725A (ko) 폐 고혈압성 질병을 억제하는 방법
JP2002509153A5 (cg-RX-API-DMAC7.html)
JP2002520282A5 (cg-RX-API-DMAC7.html)
JP2002537258A5 (cg-RX-API-DMAC7.html)
JP2002505286A5 (cg-RX-API-DMAC7.html)
JP2003520208A5 (cg-RX-API-DMAC7.html)
JP2009527505A5 (cg-RX-API-DMAC7.html)
JP2002526539A5 (cg-RX-API-DMAC7.html)
JP2002506864A5 (cg-RX-API-DMAC7.html)
JP2002542298A5 (cg-RX-API-DMAC7.html)
RU2002130247A (ru) Производные оксадиазола, обладающие противоопухолевым действием